HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Hybrid Imaging

Hybrid Imaging

Hybrid imaging, a cutting-edge technique in cancer research, combines two or more imaging modalities to provide comprehensive information about tumor biology, morphology, and function. Typically, it merges anatomical imaging, like CT or MRI, with functional imaging such as PET or SPECT. This synergy enables more accurate tumor localization, characterization, and staging, crucial for treatment planning and monitoring. For instance, PET/CT combines positron emission tomography (PET) for detecting metabolic activity with computed tomography (CT) for precise anatomical localization, offering a holistic view of cancer progression. Similarly, PET/MRI pairs PET's functional data with MRI's superior soft tissue contrast, enhancing the understanding of tumor behavior. Hybrid imaging holds promise for personalized cancer management, facilitating early detection, treatment optimization, and assessing therapeutic response, ultimately improving patient outcomes.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp